CRP and COVID-19: CRP is a good inflammatory marker revealing the association between diabetes and adverse COVID-19 outcomes, including the need for ICU admission, dyspnea, and length of stay (Koh et al., 2021), whereas fibrinogen for coagulation dysfunction (Varikasuvu et al., 2021).